Life-sciences company (now renamed TransformaBio, Inc
Life-sciences company (now renamed TransformaBio, Inc.) developing the NanoTransformer® platform, which produces nanoparticles of poorly soluble drugs to improve solubility and bioavailability without lipids or polymers. It develops nasal powder drug-delivery products for CNS conditions, including intranasal apomorphine candidate NT-301 for Parkinson’s disease, and partners with contract manufacturers to deploy its platform.